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Abstract
Background: To evaluate the antiplaque effects of an alcohol-free mouthrinse containing essential oils—Listerine
Zero (LZ)—and an alcohol-based essential oils mouthrinse (EO+) compared with a positive control of 0.20%
chlorhexidine mouthrinse (CHX) and a negative control of a placebo solution (saline), using an in vivo plaque
regrowth model of three days.
Methods: The study was designed as a double-masked, randomized, crossover clinical trial, involving 21 volunteers
to compare four different mouthrinses, using a three-day plaque regrowth model. After receiving thorough
professional prophylaxis at baseline, over the next three days each volunteer refrained from all oral hygiene
measures and performed two daily rinses with 15 mL of the test mouthrinses. EO+ was compared with LZ. CHX
rinse served as a positive control and a placebo solution as a negative control. At the end of each experimental
period, the Plaque Index (PI) was assessed and a panelist completed through a visual analogue scale (VAS)
questionnaire evaluating the organoleptic properties of each product. Each participant underwent a 14-day
washout period and then there was another allocation.
Results: LZ showed the same inhibitory activity on plaque regrowth compared with EO+ in the whole mouth (PI =
1.72 versus 1.65, respectively), but there was less of an effect compared to the CHX (overall PI of 1.07) and a more
efficient activity than the saline solution negative control (PI = 2.31). The difference of 0.07 between LZ and EO+
was not statistically significant.
Conclusions: LZ seems to have the same inhibiting effect on plaque regrowth as EO+ and a less inhibiting effect
than the CHX control. Both LZ and EO+, as well as the CHX control, show a better inhibiting effect on plaque
regrowth than the placebo solution.
Trial registration: ClinicalTrials.gov, NCT02894593. Registered on 4 September 2016.
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Background
Plaque is a biofilm of microorganisms responsible for
the development of caries and periodontal disease. The
daily removal of supragingival dental plaque represents a
major factor in the prevention of caries, gingivitis, and
periodontitis [1, 2]. Plaque control is largely obtained by
daily effective tooth-brushing and inter-dental cleaning;
plaque removal can be improved by adding the use of a
mouthrinse.
An effective action of chemical formulation (F.D.I.
Commission 2002) (especially antiseptics) to control
plaque and gingivitis levels has been proved [3].
Most mouthrinses contain an alcohol (especially etha-
nol) in order to act as a carrier agent for active essential
oils to penetrate the plaque and to give the user a “clean
mouth sensation” [4].
The alcohol content of mouthrinses, besides having
antiseptic properties, serves the purpose of breaking
down or dissolving active principles, in addition to that
of preserving the formula components, although such
content does not directly contribute to effective biofilm
and gingivitis control [5]. However, there are some con-
traindications in the use of alcohol-based mouthrinses,
like the use by infants, pregnant women, alcohol addicts,
and patients with mucosal injuries. There are also some
undesirable effects, like burning or a sore sensation, or a
painful sensation for patients with existing soft tissue in-
juries, or a perception of dryness in the mouth [5].
In order to avoid the use of alcohol-based mouthrinses
in particular conditions, scientific interest is becoming
more widespread in introducing a mouthrinse with
strong anti-plaque qualities and no alcoholic ingredients.
One of these product is the alcohol-free essential oils
mouthrinse Listerine Zero (LZ), which has little docu-
mentation with regard to its anti-plaque effects.
Specific objective
The aim of this study was to evaluate the antiplaque ef-
fects of an alcohol-free essential oils mouthrinse (LZ)
and an alcohol-based essential oils mouthrinse (EO+)
compared with a positive control of a 0.2% chlorhexidine
mouthrinse (CHX) and a negative control of a placebo




The study was designed as a double-masked, four-
groups, randomized, controlled, crossover clinical trial.
The study was conducted in the Division of Periodon-
tology, Dental Clinic, University of L’Aquila from January
to October 2015.
The volunteers were assigned the active or control so-
lutions in a randomized sequence. Randomization and
allocation of active or control solutions were undertaken
by a person not directly involved in the research project.
No changes to methods after the trial beginning (such as
eligibility criteria) were performed (Additional file 1).
Participants
Twenty-one (21) dental hygiene student volunteers (14
women, 7 men; age range 21–41 years; mean age 26.2 ±
4.3 years) participated in the study. The participants
were recruited through the near-graduate student who
promoted the graduation study. All of the candidates
were screened for suitability by the research team. The
selection inclusion criteria were: dentition with ≥ 20 eva-
luable teeth (minimum of five teeth per quadrant) and
age of majority; exclusion criteria were oral lesions, se-
vere periodontal problems (probing depth ≥ 5 mm or at-
tachment loss > 2 mm), and removable prostheses or
orthodontic bands/appliances. Participants allergic to
several mouthrinse components were excluded from the
study. All eligible volunteers were given oral and written
information about the products and the purpose of the
study and were asked to sign an informed consent form.
The study flow chart is shown in Fig. 1.
Regarding the habits of participants, only six partici-
pants smokers (they smoked less than five cigarettes/
day). All the participants declared themselves accus-
tomed to using mouthrinses, although not assiduously.
Moreover, all the participants said they had tried various
types of mouthrinses in the past.
Interventions
On day 1 of each of the four study periods, after baseline
examinations consisting of an oral soft and hard tissue
examination, the participants received a complete dental
prophylaxis and professional scaling and polishing to re-
move all plaque and extrinsic tooth stains. This process
was performed using hand instruments, mechanical
scalers, rotating brushes with polishing paste, and dental
floss in the interproximal areas. To ensure that all de-
posits were removed, a second polishing episode was
performed after the use of a disclosing solution. The vol-
unteers were assigned test solutions in a randomized se-
quence. The allocation of active or control solutions was
undertaken by a person not directly involved in the re-
search project. The participants received the bottles of
mouthrinses containing LZ mouthrinse, alcohol-based
EO+ mouthrinse, chlorhexidine 0.2% (CHX) mouthrinse,
and a flavored placebo solution (saline) (Table 1).
New identical and anonymous bottles were used for
each administration. All of the bottles containing mou-
thrinse were pre-weighed. All of the participants were
instructed to refrain from using any other means of oral
hygiene during the experimental period; to rinse twice
per day, in the morning and in the evening, with 15 mL
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of solution for 60 s, as their sole oral hygiene measure.
Subsequent rinsing with water was not allowed. Written
instructions were provided explaining how to use the
mouthrinse. Rinsing was performed at home without
supervision. To check for compliance, the participants
were asked to note the times of day when they rinsed.
Fig. 1 Flow chart of the study
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After three days, all of the volunteers were examined
with an erythrosine solution and the plaque in both
groups was recorded at six sites per tooth using the
Quigley and Hein index [6], as modified by Turesky et
al. [7] and further modified by Lobene et al. [8].
All of the measurements were obtained under the
same conditions by the same blinded investigator (EC).
The examiner was trained and calibrated in the plaque
scoring system. All of the returned mouthrinse bottles
were weighed to calculate the amount of mouthrinse
used and to check for compliance.
All of the volunteers then received a questionnaire
that used a visual analog scale (VAS), designed to evalu-
ate their attitudes toward the products used and espe-
cially the organoleptic properties of the mouthrinses.
The patients had to report about the flavor of the mou-
thrinse, the permanence of the sensation after the rinse,
and the eventual alteration in the taste and smell of food
and drinks. They also had to give their personal impres-
sions on the anti-plaque properties of the mouthrinse
they used. The participants marked a point on a 10-cm-
long, uncalibrated line with the negative extreme
response (0) at the left end, and the positive extreme re-
sponse (10) at the right end [9–11].
A washout period of 14 days was instituted between
the treatments [9], during which the participants re-
sumed their normal oral hygiene habits; following this
two-week washout period, all of the participants again
underwent a session of scaling to obtain a Plaque Index
(PI) of 0 and the procedures were repeated with partici-
pants using another rinse.
Data analysis
The plaque score was used as the main response vari-
able. Data analysis was performed on individual PI
means ± standard deviations calculated at the subject
level and considered both the totality of the oral cavity,
and the upper and lower anterior (incisors and canines)
and posterior (premolars and molars) sites. Data were
analyzed for normality of distribution with the Shapiro–
Wilk test. Because the data did not result in a normal
distribution, a non-parametric analysis of variance
(Friedman test) was performed to determine differences
among the tested products (total difference). In the pres-
ence of significant differences, post-hoc analysis for
comparison of pairs of treatments were made with
Wilcoxon signed-rank test with Bonferroni adjustment
for multiple comparisons, and thus significance for the
univariate analyses was assessed at p < 0.0125. Data con-
sidering the VAS scores of the questionnaire were also
analyzed using the same tests. For all other analyses, to
the exclusion therefore of post-hoc analysis, a 5% signifi-
cance level was adopted, and the data were analyzed
using the Stata/IC 12.1 statistical package.
Results
Regarding periodontal status, pre-existing periodontal
health was generally good in the whole sample. No signs
of gingivitis were present in the whole sample.
All of the participants (n = 21) completed the experi-
mental period and there were no missing values. The
returns of each product suggested acceptable compliance
with the instructions. No adverse events or side effects
were reported.
The plaque scores for each solution at the end of the
experimental period are shown in Table 2. Table 3 re-
ports post-hoc analyses.
Statistical analysis showed that there were signifi-
cant differences in the PI among the four groups
(Tables 2 and 3).
Table 1 Products and their compositions
Group Product and manufacturer Composition Instruction
LZ Listerin Zero® formulation
Johnson & Johnson Consumer Inc.
sodium fluoride 0.02%
(0.01% w/v fluoride ion),
water, sorbitol solutio, propylene glycol,
poloxamer 407, sodium lauryl sulfate flavor,
sodium benzoate phosphoric acid, eucalyptol,
methyl salicylate, thymol, sodium saccharin,
menthol, disodium phosphate, sucralose,
FD&C Red No. 40, FD&C Blue No. 1
All of the participants were instructed to
refrain from using any other means of oral
hygiene during the experimental period.
All of the participants were instructed to
rinse twice per day, in the morning and in
the evening, with 15 mL of solution for 60 s.
Subsequent rinsing with water was not allowed.
EO+ Listerine Difesa Denti e Gengive®
formulation
Johnson & Johnson Consumer Inc.
eucalyptol 0.092%;
menthol 0.042%; methyl salicylate 0.060%;
thymol 0.064%.
water, alcohol (21.3%), sorbitol, benzoic acid,
poloxamer 407, sodium benzoate, sodium
saccharin, sodium fluoride, CI 47005, CI 42053.
CHX Meridol Clorexidina 0.2%
Gaba International AG
Aqua, glycerin, sorbitol, PEG-40 hydrogenated
castor oil, clorhexidine digluconate, aroma,
citric acid, CI 42051.
Saline Hydro non-alcoholic solution flavored with
thyme oil (8 drops per liter of water)
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No statistically significant differences were observed
between LZ and EO+ products, in all the analyzed sites
(except for the vestibular and oral site) (Table 3).
The positive control (CHX) has shown the higher in-
hibitory effect on plaque regrowth compared with the
LZ and EO+ products; in fact, the mean overall PI was
1.07 with CHX compared with 1.65 for the EO+ product
and 1.72 for the LZ product. The differences between
LZ and CHX and between EO+ and CHX were all statis-
tically significant (p < 0.0125).
The placebo showed less of an effect compared with
the CHX, EO+, and LZ products, with an overall PI
of 2.31.
The participants completed the questionnaire after
each experimental period and the results are shown in
Table 4.
With regard to the participants’ taste perception
(question 1), the results demonstrated statistically
significant differences with LZ product showing the best
taste respect to the other products (7.5 for LZ product).
With regard to the participants’ alterations in taste
perception (question 3), no statistically significant differ-
ences were noted among the products.
About the sensation of plaque reduction, LZ product
was much more than the other products, with significant
differences (LZ: 6.75; EO+: 6.3; CHX: 6.25; Saline:3.2;
p < 0.0125).
Discussion
The purpose of this study was to test the effects of an
alcohol-free essential oils mouthrinse (LZ) and an
alcohol-based essential oils mouthrinse (EO+) compared
with a positive control (a commercially available CHX-
containing product) and a negative control (a flavored
saline solution as a placebo), using an in vivo plaque
growth model of three days. The results confirmed the
null hypothesis that there is no significant difference be-
tween LZ and the alcohol-based mouthrinses, while
there is a modest but statistically significant difference in
favor of the CHX product.
CHX is used as positive control because of its demon-
strated ability to reduce plaque at 0.2% [12–14].
Data collection was performed using the PI (the
Quigley and Hein Index, as modified by Turesky et al.
and further modified by Lobene et al.), rather than the
Full-Mouth Plaque Score (FMPS%), which has been
employed in other studies [15] and represents the per-
centage of teeth surfaces with plaque accumulation. The
choice of this analytical index is due to the desire to
identify whether there are particular topographical sites
in the mouth of the patients characterized by different
effects of the three different products, as proposed in an-
other study [11].
The PI was thus evaluated at nine different sites (glo-
bal, oral area, buccal area, upper jaw area, lower jaw




CHX EO+ LZ Saline
Overall 1.07 ± 0.20 1.65 ± 0.35 1.72 ± 0.36 2.31 ± 0.42 <0.0001
Vestibular + oral 1.07 ± 0.20 1.67 ± 0.35 1.73 ± 0.36 2.32 ± 0.42 < 0.0001
All vestibular 1.29 ± 0.35 1.99 ± 0.46 2.09 ± 0.43 2.85 ± 0.61 < 0.0001
Oral 0.85 ± 0.24 1.34 ± 0.31 1.37 ± 0.38 1.78 ± 0.36 < 0.0001
Upper arch 1.08 ± 0.28 1.64 ± 0.37 1.77 ± 0.41 2.47 ± 0.44 < 0.0001
Lower arch 1.05 ± 0.24 1.69 ± 0.44 1.69 ± 0.36 2.17 ± 0.46 < 0.0001
Molar 1.16 ± 0.29 2.18 ± 0.48 2.15 ± 0.43 2.54 ± 0.46 < 0.0001
Premolars 0.97 ± 0.26 1.54 ± 0.40 1.67 ± 0.49 2.24 ± 0.38 < 0.0001
Canines 1.05 ± 0.30 1.45 ± 0.43 1.57 ± 0.36 2.30 ± 0.53 < 0.0001
Incisors 1.07 ± 0.41 1.40 ± 0.39 1.47 ± 0.47 2.17 ± 0.56 0.0001
aUsing Friedman test
Table 3 Post-hoc analysis
p valuea p valuea p valuea p valuea
CHX vs. EO+ EO+ vs. LZ LZ vs. Saline CHX vs. LZ
Overall 0.0001 n.s 0.0002 0.0002
Vestibular + oral 0.0001 0.0001 0.0002 0.0001
All vestibular 0.0002 n.s 0.0002 0.0002
Oral 0.0001 n.s 0.0028 0.0001
Upper arch 0.0001 n.s 0.0002 0.0002
Lower arch 0.0001 n.s 0.0015 0.0002
Molar 0.0001 n.s 0.0124 0.0001
Premolars 0.0002 n.s 0.0005 0.0002
Canines 0.0006 n.s 0.0001 0.0010
Incisors 0.0100 n.s 0.0006 0.0072
aUsing Wilcoxon signed-rank test with Bonferroni adjustment for multiple
comparison, p < 0.0125
n.s. no statistically significant difference between each treatment, p > 0.0125
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area, molar area, bicuspid area, canine area, and incisive
area). The analysis of nine different intra-oral sites re-
sulted in the conclusion that there are no substantial dif-
ferences in the effects of the LZ and EO+ products in
different areas of the mouth; this finding suggests that
both mouthrinses have acceptable ability to be effective
in all of the tested areas of the mouth and have substan-
tially the same effects on all of these areas. In this study,
plaque formation is evaluated only macroscopically,
using the PI and not microscopically (through the bac-
terial count or the presence of specific periopathogens),
in order to point out a clinical parameter that can be
easily monitored by professionals, to control the home
oral hygiene habits of patients.
All the tested products were safe and well tolerated by
the patients, although the early follow-up limited the as-
sessment of side effects, as previously hypothesized [16].
The efficacy of LZ in reducing plaque and gingivitis
when compared to a placebo (a 5% hydro-alcohol mou-
thrinse), was first evidenced by Charles et al. [17] in a
single-center, randomized, examiner-blind, two-week, no
oral hygiene, parallel group, controlled clinical trial on
90 participants. LZ was more effective (p < 0.001) than
the negative control in reducing plaque (whole mouth
mean PI) and gingivitis (whole mouth mean Modified
Gingival Index), and in reducing gingival bleedings for
the secondary efficacy endpoint (Gingival Bleeding
Index).
Cortelli et al. [18] also tested a LZ mouthrinse
compared with a placebo (flavored and colored 5%
hydro-alcohol mouthrinse) and with an alcohol-free
cetylpyridinium chloride (CPC) containing mouthrinse,
in a six-month, examiner-blind, randomized, parallel
group, controlled clinical trial. The results on the 311
participants who completed the study showed that LZ
had a superior efficacy in reducing plaque (whole mouth
mean PI) and gingivitis (whole mouth mean Modified
Gingival Index) compared with both negative control
and alcohol-free CPC containing mouthrinse. However,
in that study, the efficacy of LZ was not compared with
an alcohol-based essential oils mouthrinse. The partici-
pants were randomized just to one of the two treatment
groups and no liking ratings questionnaire followed the
test.
Our trial is the first to compare LZ with an alcohol-
based mouthrinse, a CHX mouthrinse, and a placebo
control, and to test each of the four solutions on the
whole group of volunteers after a two-week washout
period and a session of scaling (to obtain a PI of 0) be-
fore the use of each solution. The aim of the current
study was to evaluate the plaque regrowth index not
only over the mouth, but in different sites: global ves-
tibular, oral, upper arch, lower arch, molars, premolars,
canines, and incisors. Our study also showed a liking rat-
ing scale determined by VAS respect to taste perception,
duration of taste, alteration in taste perception, and con-
venience of use.
The pilot and feasibility study by Chalhoub et al.
[19] was concerned about the effectiveness of an
alcohol-free essential oils mouthwash (LZ) in institu-
tionalized elders receiving long-term care. However,
their study protocol encountered several problems,
both in recruitment and in execution of the protocol;
only 18 participants of the initial 25 completed the
study. They were divided in two groups: a test group
rinsed with 15 mL alcohol-free essential oils mouth-
wash twice a day for 30 s and a control group rinsed
with 15 mL of tap water twice a day for 30 s. PI,
Table 4 Questionnaire responses (mean and SD) determined by VAS, n = 21
Post-hoc analysis (p valuea)
Questionnaire questions Answers from
(0) to (10)





















0.0012 n.s 0.0116 0.0002 0.0069












0.0114 n.s n.s n.s 0.0413












n.s. n.s. n.s. n.s. n.s.












0.0016 n.s n.s 0.0003 n.s












n.s. n.s. n.s. n.s. n.s.












0.0030 n.s. n.s. 0.0011 n.s.
aUsing Wilcoxon signed-rank test with Bonferroni adjustment for multiple comparison, p < 0.0125
bUsing Friedman test, p < 0.05
n.s. no statistically significant difference between each treatment, p > 0.0125
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denture cleanliness, and salivary levels were measured
at days 0, 22, and 45. The conclusion was that the
use of an alcohol-free essential oils mouthwash is not
more effective than the tap water in institutionalized
elders receiving long-term care. Nevertheless, the
small sample size of the participants, the several limi-
tations of the study, and the problems encountered
during the execution show that larger studies about
the use of an alcohol-free essential oils mouthwash in
institutionalized seniors are needed.
Ulkur et al. [20], evaluating bacteria counts, show that
after using an alcohol-free essential oils mouthwash for
four days, the Streptococcus mutans colony counts are
slightly higher compared with alcohol-based essential
oils and alcohol-free 0.1% CHX mouthrinse, while no
difference appears on the tongue surface.
They conducted a double-blind study to compare
an alcohol-free 0.1% CHX mouthrinse, an alcohol-
based essential oils mouthrinse, an alcohol-free essen-
tial oils mouthrinse, and a negative control in order
to evaluate their effects on the S. mutans colonies re-
duction, on the teeth and tongue surfaces. All the pa-
tients had brackets on both the upper and lower
dental arches. The patients were instructed to avoid
any mechanical cleaning with toothbrushes or tooth-
picks for four days. The study collected samples at
day 0, after a professional cleaning, and after a four-
day plaque regrowth period, when between-group dif-
ferences were detected.
As it appears, the method of Ulkur’s study contem-
plates different quantities, duration, and times-a-day
rinse directions for each of the tested solutions, con-
ditions that might have had effects on the resulting
counts. Moreover, each of the volunteer groups tested
just one type of mouthrinse, so that personal charac-
teristics of the patients, such as salivary buffer cap-
acity, pH, or flow rate, could have had an effect on
the results.
Traditional essential oils with alcohol have been used
for years as adjuncts to brushing in addressing oral hy-
giene, so their effectiveness in controlling plaque and
gingivitis is well documented in the literature [21–26];
they appeared equivalent to CHX for long-term control
of gingival inflammation, but CHX appears to perform
better than alcohol based essential oils mouthrinses in
plaque control [27].
However, little is known about the new formulations
of essential oils mouthrinse without alcohol (alcohol-free
EO), such as LZ, used in this study [9, 10].
Despite the early follow-up, patients clearly judged
the tastes of the products, claiming to prefer, in a sta-
tistically significant manner, the flavors of the LZ
product to the flavor of the other products. LZ was
also judged as equally effective in reducing plaque
respect to CHX, which does not correspond to what
was found with the PI.
Conclusions
The lowest values for the PI were obtained with
CHX. LZ showed the same effect on plaque regrowth
as the alcohol-based EO+ mouthrinse. Due to the
short follow-up, these results could be considered
preliminary and we cannot exclude that the tested
products could have other effects over the medium or
long term.
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Clinical relevance
Scientific rationale for study
Scientific interest is becoming more widespread in introducing an alcohol-
free mouthrinse with strong anti-plaque qualities, in order to avoid having to
use alcohol-based products.
Principal findings
LZ mouthrinse seems to have the same inhibiting effect on plaque regrowth
as the alcohol-based mouthrinse (EO+), but the lowest values for the PI were
obtained with CHX, while the highest ones were obtained with the placebo
solution
Practical implications
LZ mouthrinse can be used for patients who are affected by periodontal
disease.
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